Bizarre Patents
Vehicular Impact Signaling Device
An apparatus for the deployment of a visible plume to alert other motorists that a proximate motor vehicle has been involved in a collision.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7846441 | Treatment with anti-ErbB2 antibodies The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an an... | 12/07/2010 |
| 7674589 | Methods for tissue analysis This invention relates to methods of analyzing a tissue sample from a subject. In particular the invention combines morphological staining and/or immunohistochemistry (IHC) with fluorescence in situ hybridization (FISH) within the same section of a tissue sample. Th... | 03/09/2010 |
| 7501122 | Treatment with anti-ErbB2 antibody combinations The present application describes methods for treating ErbB-expressing cancer with anti-ErbB2 antibody combinations. ... | 03/10/2009 |
| 7485704 | Reducing protein A leaching during protein A affinity chromatography A method for reducing leaching of protein A during protein A affinity chromatography is described which involves reducing temperature or pH of, or by adding one or more protease inhibitors to, a composition that is subjected to protein A affinity chromatography.... | 02/03/2009 |
| 7468252 | Methods for tissue analysis This invention relates to methods of analyzing a tissue sample from a subject. In particular, the invention combines morphological staining and/or immunohistochemistry (IHC) with fluorescence in situ hybridization (FISH) within the same section of a tissue sample. T... | 12/23/2008 |
| 7455991 | Serpentine transmembrane antigens expressed in human cancers and uses thereof Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed “STEAP” ... | 11/25/2008 |
| 7435797 | Anti-HER2 antibody variants The present invention concerns novel antibody variants, particularly anti-HER2 antibody variants having substitutions at positions within the variable domains of the heavy and light chains ... | 10/14/2008 |
| 7332579 | Antibodies to human ErbB4 The present invention concerns isolated antibodies that specifically bind to the human ErbB4 of SEQ ID NO:2, as well as humanized antibodies, human antibodies and antibody fragments, as well as bispecific antibodies capable of binding both the human ErbB4 of SEQ ID ... | 02/19/2008 |
| 7244836 | Tumor necrosis factor receptor-associated factors The invention concerns new tumor necrosis factor receptor associated factors, designated TRAF. The new factors are capable of specific association with the intracellular domain of the type 2 TNF receptor (TNF-R2), and are involved in the mediation of TNF biological ... | 07/17/2007 |
| 7163701 | Controlled release microencapsulated NGF formulation NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF (“rhNGF”) are provided that yield enhanced stability of NGF for use in promoting nerve c... | 01/16/2007 |
| 7144983 | Pantropic neurotrophic factors Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neu... | 12/05/2006 |
| 7067484 | AL-1 neurotrophic factor treatments The present invention provides nucleic acids encoding AL-1 protein, as well as AL-1 protein produced by recombinant DNA methods. Such AL-1 protein is useful in preparing antibodies and in diagnosing and treating various neuronal disorders. ... | 06/27/2006 |
| 6974798 | Treatment of balance impairments Compositions and methods are provided for prophylactic or therapeutic treatment of balance impairments involving neuronal damage, loss, or degeneration, preferably of vestibular ganglion neurons, in an animal by administration of an effective amount of a trkB or trk... | 12/13/2005 |
| 6964947 | Stabilizing formulation for NGF Formulations are provided comprising NGF and acetate-containing buffer from pH 5 to 6 that provide enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. ... | 11/15/2005 |
| 6953844 | Isolation of neurotrophins from a mixture containing neurotrophin variants using hydrophobic interaction chromatography Methods are provided for large scale purification of neurotrophins, including mature NGF, suitable for clinical use. The methods provide means to separate neurotrophins from various less desirable misprocessed, misfolded, size, glycosylated, or charge forms. Composi... | 10/11/2005 |
| 6812330 | Isolation of neurotrophins from a mixture containing other proteins and neurotrophin variants using hydrophobic interaction chromatography Methods are provided for large scale purification of neurotrophins, including mature NGF, suitable for clinical use. The methods provide means to separate neurotrophins from various less desirable misprocessed, misfolded, size, glycosylated, or charge forms. Composi... | 11/02/2004 |
| 6432677 | Non-human animal interferons Distinct -, ଲ- and γ-interferon genes from various animal species have been identified, cloned and expressed to produce the corresponding non-human animal interferon proteins. Specifically disclosed are interferons of bovine, porcine, feline... | 08/13/2002 |
| 6299877 | Type I interferons The invention concerns a novel human interferon-&3xb5;, originally designated PRO655, and its variants and derivatives. The novel interferon is related to but distinct from members of the IFN- family and from IFNs-ଲ and -γ. Nucleic acid enco... | 10/09/2001 |
| 6299869 | Human interferon-epsilon: a type I interferon The invention concerns a human interferon-&3xb5;, originally designated PRO655, and its variants and derivatives. The interferon is related to but distinct from members of the IFN- family and from IFNs-ଲ and -γ. Nucleic acid encoding the pol... | 10/09/2001 |
| 6300475 | Interferon PRO655 The invention concerns a human interferon, designated PRO655, and its variants and derivatives. The interferon is related to but distinct from members of the IFN- family and from IFNs-ଲ and -γ. Nucleic acid encoding the polypeptide, and meth... | 10/09/2001 |
